DSM-Firmenich AG (FRA:ZX6)
Germany · Delayed Price · Currency is EUR 66.34
+0.82 (1.25%)
At close: Jan 30, 2026
DSM-Firmenich AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 13,011 | 12,799 | 10,627 | 8,390 | 7,269 | 8,106 | |
Revenue Growth (YoY) | 4.46% | 20.44% | 26.66% | 15.42% | -10.33% | 1.35% |
Cost of Revenue | 8,454 | 8,554 | 8,016 | 5,700 | 4,657 | 5,330 |
Gross Profit | 4,557 | 4,245 | 2,611 | 2,690 | 2,612 | 2,776 |
Selling, General & Admin | 2,848 | 2,848 | 2,535 | 1,772 | 1,649 | 1,622 |
Research & Development | 888 | 888 | 652 | 295 | 274 | 398 |
Other Operating Expenses | -317 | - | -16 | -29 | -21 | 84 |
Operating Expenses | 3,419 | 3,736 | 3,171 | 2,038 | 1,902 | 2,104 |
Operating Income | 1,138 | 509 | -560 | 652 | 710 | 672 |
Interest Expense | -190 | -162 | -138 | -104 | -92 | -90 |
Interest & Investment Income | 70 | 70 | 95 | 22 | 3 | 17 |
Earnings From Equity Investments | -52 | -5 | -6 | 12 | 16 | -64 |
Currency Exchange Gain (Loss) | -41 | -41 | -86 | -20 | -8 | -22 |
Other Non Operating Income (Expenses) | 1 | 1 | -26 | -1 | -9 | 14 |
EBT Excluding Unusual Items | 926 | 372 | -721 | 561 | 620 | 527 |
Merger & Restructuring Charges | -39 | -39 | -59 | -3 | -20 | -55 |
Gain (Loss) on Sale of Investments | 5 | 5 | -1 | -7 | 326 | 32 |
Gain (Loss) on Sale of Assets | 47 | 47 | 17 | 31 | 13 | - |
Legal Settlements | - | - | - | - | 2 | 23 |
Other Unusual Items | 21 | 21 | 57 | 5 | 2 | 7 |
Pretax Income | 981 | 427 | -654 | 599 | 953 | 563 |
Income Tax Expense | 210 | 147 | -18 | 124 | 123 | 106 |
Earnings From Continuing Operations | 771 | 280 | -636 | 475 | 830 | 457 |
Earnings From Discontinued Operations | - | - | 2,789 | 1,240 | 850 | 51 |
Net Income to Company | 771 | 280 | 2,153 | 1,715 | 1,680 | 508 |
Minority Interest in Earnings | -53 | -30 | -16 | -15 | -4 | -2 |
Net Income | 718 | 250 | 2,137 | 1,700 | 1,676 | 506 |
Preferred Dividends & Other Adjustments | - | - | 6 | 6 | 6 | 7 |
Net Income to Common | 718 | 250 | 2,131 | 1,694 | 1,670 | 499 |
Net Income Growth | - | -88.30% | 25.71% | 1.43% | 231.23% | -33.25% |
Shares Outstanding (Basic) | 264 | 265 | 233 | 173 | 173 | 172 |
Shares Outstanding (Diluted) | 264 | 265 | 233 | 173 | 173 | 172 |
Shares Change (YoY) | -0.58% | 13.37% | 34.68% | -0.06% | 0.56% | -2.48% |
EPS (Basic) | 2.72 | 0.94 | 9.14 | 9.80 | 9.67 | 2.91 |
EPS (Diluted) | 2.72 | 0.94 | 9.14 | 9.77 | 9.63 | 2.89 |
EPS Growth | - | -89.71% | -6.47% | 1.45% | 233.22% | -31.84% |
Free Cash Flow | 881 | 1,133 | 710 | 459 | 994 | 1,036 |
Free Cash Flow Per Share | 3.34 | 4.28 | 3.04 | 2.65 | 5.73 | 6.01 |
Dividend Per Share | 2.500 | 2.500 | 2.500 | 2.530 | 2.500 | 2.400 |
Dividend Growth | - | - | -1.19% | 1.20% | 4.17% | - |
Gross Margin | 35.02% | 33.17% | 24.57% | 32.06% | 35.93% | 34.25% |
Operating Margin | 8.75% | 3.98% | -5.27% | 7.77% | 9.77% | 8.29% |
Profit Margin | 5.52% | 1.95% | 20.05% | 20.19% | 22.97% | 6.16% |
Free Cash Flow Margin | 6.77% | 8.85% | 6.68% | 5.47% | 13.68% | 12.78% |
EBITDA | 2,213 | 1,599 | 345 | 1,234 | 1,305 | 1,209 |
EBITDA Margin | 17.01% | 12.49% | 3.25% | 14.71% | 17.95% | 14.92% |
D&A For EBITDA | 1,075 | 1,090 | 905 | 582 | 595 | 537 |
EBIT | 1,138 | 509 | -560 | 652 | 710 | 672 |
EBIT Margin | 8.75% | 3.98% | -5.27% | 7.77% | 9.77% | 8.29% |
Effective Tax Rate | 21.41% | 34.43% | - | 20.70% | 12.91% | 18.83% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.